EP400NL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.369200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.736200E-01
Normal-vs-Stage2
5.174600E-01
Normal-vs-Stage3
4.108800E-01
Normal-vs-Stage4
5.184600E-01
Stage1-vs-Stage2
5.994000E-02
Stage1-vs-Stage3
3.659600E-01
Stage1-vs-Stage4
5.396200E-01
Stage2-vs-Stage3
8.820000E-01
Stage2-vs-Stage4
6.742400E-01
Stage3-vs-Stage4
7.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.583000E-01
Normal-vs-AfricanAmerican
3.034400E-01
Normal-vs-Asian
4.809400E-01
Caucasian-vs-AfricanAmerican
1.444050E-02
Caucasian-vs-Asian
3.978000E-01
AfricanAmerican-vs-Asian
9.721600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.130800E-01
Normal-vs-Female
5.706800E-01
Male-vs-Female
2.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.726000E-01
Normal-vs-Age(41-60Yrs)
5.409200E-01
Normal-vs-Age(61-80Yrs)
5.284600E-01
Normal-vs-Age(81-100Yrs)
5.227400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.341400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.215400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.181600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.219000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.152400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.524000E-01
Normal-vs-Daily Drinker
5.198400E-01
Normal-vs-Weekly Drinker
5.882600E-01
Normal-vs-Occasional Drinker
5.023800E-01
Normal-vs-Social Drinker
6.419400E-01
Non Drinker-vs-Daily Drinker
7.433600E-01
Non Drinker-vs-Weekly Drinker
1.527020E-01
Non Drinker-vs-Occasional Drinker
5.594200E-01
Non Drinker-vs-Social Drinker
4.956200E-01
Daily Drinker-vs-Weekly Drinker
7.107900E-02
Daily Drinker-vs-Occasional Drinker
8.349400E-01
Daily Drinker-vs-Social Drinker
2.946600E-01
Weekly Drinker-vs-Occasional Drinker
5.977600E-02
Weekly Drinker-vs-Social Drinker
4.675600E-01
Occasional Drinker-vs-Social Drinker
2.100400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.175000E-01
Normal-vs-Grade 2
9.714200E-01
Normal-vs-Grade 3
9.403200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.026000E-01
Grade 1-vs-Grade 3
7.129200E-01
Grade 1-vs-Grade 4
8.175000E-01
Grade 2-vs-Grade 3
6.148400E-01
Grade 2-vs-Grade 4
9.714200E-01
Grade 3-vs-Grade 4
9.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.136200E-01
Normal-vs-NonDiabetic
5.510800E-01
Diabetic-vs-NonDiabetic
5.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.812800E-01
Normal-vs-NoPancreatitis
5.451800E-01
Pancreatitis-vs-NoPancreatitis
4.764200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.592800E-01
Normal-vs-N1
5.164400E-01
N0-vs-N1
4.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.248800E-01
Normal-vs-TP53-NonMutant
5.448400E-01
TP53-Mutant-vs-TP53-NonMutant
7.394200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
